Data gathered: January 2
AI Stock Analysis - Schrodinger (SDGR)
Analysis generated December 9, 2024. Powered by Chat GPT.
Schrodinger, Inc. is a company that leverages sophisticated computational platforms to accelerate drug discovery and materials design. Their proprietary software allows for drug discovery and materials development, providing scientists with an innovative and streamlined process to predict molecular properties and behaviors. This technology-driven approach positions Schrodinger at the intersection of science and technology, offering vast potential for growth and expansion in various industries.
Stock Alerts - Schrodinger (SDGR)
 |
Schrodinger | January 2 Price is up by 5.9% in the last 24h. |
|
Schrodinger | December 27 Price is down by -5.3% in the last 24h. |
|
Schrodinger | December 19 Price is down by -5.6% in the last 24h. |
|
Schrodinger | December 18 Price is down by -6% in the last 24h. |
Alternative Data for Schrodinger
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 34 | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 91,000 | Sign up | Sign up | Sign up |
| Employee Rating | 86 | Sign up | Sign up | Sign up |
| Google Trends | 50 | Sign up | Sign up | Sign up |
| Patents | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 13 | Sign up | Sign up | Sign up |
| Facebook Followers | 537 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,272 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,115 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 81 | Sign up | Sign up | Sign up |
| Linkedin Employees | 990 | Sign up | Sign up | Sign up |
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.
| Price | $20.37 |
| Target Price | Sign up |
| Volume | 234,230 |
| Market Cap | $1.41B |
| Year Range | $16.98 - $25.26 |
| Dividend Yield | 0% |
| PE Ratio | 46.78 |
| Analyst Rating | 71% buy |
| Industry | Drug Manufacturers |
In the news
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(4)December 17 - Finnhub |
|
 |
Schrodinger announces expanded license agreement with NovartisNovember 12 - Yahoo |
Schrodinger Reports Third Quarter 2024 Financial ResultsNovember 12 - Finnhub |
|
Schrodinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with NovartisNovember 12 - Finnhub |
|
 |
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...November 12 - Yahoo |
Q3 2024 Schrodinger Inc Earnings CallNovember 12 - Yahoo |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 35M | 18M | 18M | -38M | 0 | 0.000 |
| Q2 '24 | 47M | 16M | 31M | -54M | -51M | -0.740 |
| Q1 '24 | 37M | 18M | 19M | -55M | -74M | -0.760 |
| Q4 '23 | 74M | 17M | 58M | -31M | -28M | -0.410 |
| Q3 '23 | 43M | 19M | 24M | -62M | -40M | -0.860 |
Insider Transactions View All
| Dugan Margaret filed to sell 13,469 shares at $17.8. October 16 '24 |
| Porges Geoffrey Craig filed to sell 5,685 shares at $26.4. March 5 '24 |
| Lorton Kenneth Patrick filed to sell 37,388 shares at $40.1. August 10 '23 |
| Tran Yvonne filed to sell 12,721 shares at $50. July 3 '23 |
| Tran Yvonne filed to sell 12,721 shares at $40. May 24 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$144.57 0% | 39 |
 |
Eli Lilly and CompanyLLY |
$781 1.2% | 54 |
 |
PfizerPFE |
$26.75 0.8% | 46 |
 |
AstrazenecaAZN |
$66.13 0.9% | 44 |
 |
AbbVieABBV |
$178.27 0.3% | 47 |
Read more about Schrodinger (SDGR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Schrodinger?
The Market Cap of Schrodinger is $1.41B.
What is Schrodinger's PE Ratio?
As of today, Schrodinger's PE (Price to Earnings) ratio is 46.78.
What is the current stock price of Schrodinger?
Currently, the price of one share of Schrodinger stock is $20.37.
How can I analyze the SDGR stock price chart for investment decisions?
The SDGR stock price chart above provides a comprehensive visual representation of Schrodinger's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Schrodinger shares. Our platform offers an up-to-date SDGR stock price chart, along with technical data analysis and alternative data insights.
Does SDGR offer dividends to its shareholders?
As of our latest update, Schrodinger (SDGR) does not offer dividends to its shareholders. Investors interested in Schrodinger should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Schrodinger?
Some of the similar stocks of Schrodinger are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.